Myozyme IV infusion 50mg, containing Alglucosidase alpha (genetically recombinant), is manufactured by Sanofi. This injectable drug, with YJ code 3959412F1021 and standard 50mg x 1 bottle, is an enzyme replacement therapy used to treat Pompe disease (GAA deficiency) in infants and pediatric patients.
Myozyme IV infusion 50mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →